Table 2 Duration and dose of L-AMB treatment.
L-AMB treatment | Cases (%) (N = 507) | Median |
|---|---|---|
Administration duration (days) | 11 | |
< 7 | 147 (29%) | |
≥ 7 to < 14 | 145 (29%) | |
≥ 14 to < 21 | 97 (19%) | |
≥ 21 to < 28 | 50 (10%) | |
≥ 28 | 68 (13%) | |
Mean daily dose (mg/kg/day) | 2.5 | |
< 2 | 110 (22%) | |
≥ 2 to < 2.5 | 147 (29%) | |
≥ 2.5 to < 3 | 144 (28%) | |
≥ 3 | 106 (21%) | |
